AACR Cancer Progress Report

Cancer immunotherapeutics, which unleash a patient’s immune system to fight the disease, have emerged as one of the most exciting new treatment approaches.

An estimated one in four cancer cases diagnosed each year in the United States is the result of potentially preventable risk factors.

Advances in precision medicine are offering clinicians a new arsenal of molecularly targeted therapeutics against cancer.